fda import alert semaglutide tirzepatide green list glp-1 2025 creates 'green list' of drug ingredients approved for entry in the U.S For more information please visit – FDA Import Alert 66-80: GLP-1

Quartey noted that this side effect is not unique to GLP-1 receptor agonists and can occur when the drugs or other types of drugs are absorbed and released into the saliva, thereby altering the sense of taste

Watch the full interview above

Published clinical pharmacokinetic studies comparing IM injection sites show that peak plasma concentration (Cmax) values can vary by 1525% between different IM sites for the same compound and dose, making site consistency critical for reproducible subcutaneous vs intramuscular peptide injection research outcomes

Estimated glucose disposal rate predicts mortality in adults with type 1 diabetes